- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01441843
Resistance Under the Microscope
Resistance Under the Microscope; a Randomized Placebo Controlled Parallel Group Design
The purpose of this study is to determine whether lorazepam, which is used to lower preoperative anxiety, also improves postoperative recovery.
This study data will also be used for further research aiming to identify vulnerable patients in the day-case surgery setting.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Since the early 1980s, the investigators have seen a shift towards day-case surgery. Before surgery, many patients have negative feelings about the surgical procedure. These anxieties have various negative effects. To reduce this resistance preoperative administration of an anxiolytic drug is administered, typically a benzodiazepine. The investigators know that benzodiazepines are effective in reducing anxiety, but up to now there is nog good scientific evidence about the effectiveness of lorazepam on the quality of recovery in day-case surgery patients.
The ultimate goal of our research project is to identify patients who would benefit from preoperative benzodiazepine administration and who not. Identification would substantially contribute to optimal medical decision making.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Rotterdam, Netherlands, 3015CE
- Erasmus University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients > 18 years admitted to the Day-Case Surgery Department Erasmus MC
Exclusion Criteria:
- insufficient command of the Dutch language
- ophthalmology surgery
- Extracorporeal Shock Wave Lithotripsy (ESWL)-, Gastrointestinal endoscopic intervention, Botox-, Abortion and Pain treatment
- Use of psychopharmaceuticals
- Contra-indication of lorazepam use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Lorazepam
Lorazepam 4mg/4ml
|
Once 1mg <75kg body weight, 1.5mg 75kg and >75kg body weight, IV, before surgery
Other Names:
|
Placebo Comparator: NaCl 0.9%
NaCl 0.9% 4ml
|
Once 1ml <75kg body weight, 1.5ml 75kg or >75kg body weight, IV, before surgery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Recovery Score
Time Frame: Baseline; first postoperative working day; seventh postoperative day.
|
The Quality of Recovery Score - 40 (QoR-40), a 40-item scale, is used to assess the quality of recovery. Each item is rated on a five-point Likert scale (1-5), and the QoR-40 score is calculated as the sum of the scores on these items. Minimal possible score = 40, maximal possible score = 200. A higher score indicates a higher level of quality of recovery. |
Baseline; first postoperative working day; seventh postoperative day.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety
Time Frame: baseline; after surgery but before discharge; 1 week after surgery
|
The State-Trait Anxiety Inventory (STAI) is used to assess anxiety.
Scores are calculated by summing the scores on the items, and a higher score indicates a higher level of anxiety.
|
baseline; after surgery but before discharge; 1 week after surgery
|
Fatigue
Time Frame: baseline; 1 week after surgery
|
The Multidimensional Fatigue Inventory (MFI) is used to assess the change in fatigue.
The MFI is a self-report instrument designed to measure fatigue.
Scores are calculated by summing the scores on the items, and a higher score indicates a higher level of fatigue.
|
baseline; 1 week after surgery
|
Aggression Regulation
Time Frame: baseline; 1 week after surgery
|
The State-Trait Anger Scale (STAS) is used to assess the aggression regulation.
STAS is one of the most used tools for measuring aggression.
Scores are calculated by summing the scores on the items, and a higher score indicates a higher level of aggression
|
baseline; 1 week after surgery
|
Depressive Mood
Time Frame: baseline; 1 week after surgery
|
The Hospital Anxiety and Depression Scale (HADS) is used to assess the change in depression.
The HADS is a well known international outcome measurement for anxiety and depression.
It is often used in the clinical setting.
Scores are calculated by summing the scores on the items, and a higher score indicates a higher level of depression.
|
baseline; 1 week after surgery
|
Somatic Symptoms and Complaints
Time Frame: Baseline; first postoperative working day; 1 week after surgery
|
Medical records are used to assess somatic symptoms and complaints.
Next to the medical records, dimensions of the QoR-40 (physical comfort, physical independence and pain) are used to measure somatic symptoms and complaints.
|
Baseline; first postoperative working day; 1 week after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Markus Klimek, MD, PhD, Erasmus Medical Center
Publications and helpful links
General Publications
- Mijderwijk H, van Beek S, Klimek M, Duivenvoorden HJ, Grune F, Stolker RJ. Lorazepam does not improve the quality of recovery in day-case surgery patients: a randomised placebo-controlled clinical trial. Eur J Anaesthesiol. 2013 Dec;30(12):743-51. doi: 10.1097/EJA.0b013e328361d395.
- Mijderwijk H, Stolker RJ, Duivenvoorden HJ, Klimek M, Steyerberg EW. Clinical prediction model to identify vulnerable patients in ambulatory surgery: towards optimal medical decision-making. Can J Anaesth. 2016 Sep;63(9):1022-32. doi: 10.1007/s12630-016-0673-3. Epub 2016 Jun 9.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Antiemetics
- Gastrointestinal Agents
- Tranquilizing Agents
- Psychotropic Drugs
- Hypnotics and Sedatives
- Anti-Anxiety Agents
- GABA Modulators
- GABA Agents
- Anticonvulsants
- Lorazepam
Other Study ID Numbers
- NL3253507810
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Consciousness and Healing InitiativeNot yet recruitingAnxiety | Anxiety State | Mental Health Issue | Anxiety Generalized
-
University of MichiganBrain & Behavior Research FoundationRecruitingGeneralized Anxiety Disorder | Anxiety | Social Anxiety Disorder | Panic DisorderUnited States
Clinical Trials on Lorazepam
-
Massachusetts General HospitalUCB PharmaWithdrawn
-
Johns Hopkins UniversitySociety of Family PlanningCompletedOral Sedation and Cervical Dilator PainUnited States
-
Mayo ClinicCompletedAlzheimer's Disease (AD)United States
-
Eunice Kennedy Shriver National Institute of Child...The Emmes Company, LLCCompleted
-
Laureate Institute for Brain Research, Inc.National Institute of Mental Health (NIMH); California Institute of TechnologyRecruitingDepression | Anxiety Disorders | Fear | Depression, Anxiety | Anxiety and Fear | Anxious DepressionUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Northwell HealthWithdrawn
-
Mayo ClinicNational Institute of Mental Health (NIMH)Completed
-
Edgemont Pharmaceuticals, LLCCompletedGeneralized Anxiety Disorder (GAD)United States
-
St. Justine's HospitalCompleted